Back to Journals » OncoTargets and Therapy

PubMed
SJR OA
CiteScore
Impact Factor

OncoTargets and Therapy

COPE logo
ISSN: 1178-6930

Journal Image

Editor-in-Chief: Professor Gaetano Romano

OncoTargets and Therapy is an international, peer-reviewed journal focusing on the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

This journal offers Accelerated Publication.

Articles:

Latest articles:

- 5 records -

Original Research

ELOVL6 Promotes the Proliferation and Migration of Oral Squamous Cell Carcinoma Cells Through Fatty Acid Remodelling and ROS Modulation in vitro

You J, Li L, Yang J, Xu J, Qian B, Qian L

OncoTargets and Therapy 2026, 19:592523

Published Date: 26 June 2026

Original Research

Multi-Omics Analysis Identifies Phosphoglucomutase 2 as a Potential Target to Alleviate Chemoradiotherapy Resistance in Cervical Cancer Cells

Yang H, Zheng Q, Li X, Wang J

OncoTargets and Therapy 2026, 19:613657

Published Date: 16 June 2026

Review

Mechanisms and Emerging Strategies to Overcome Immunotherapy Resistance in Cold Tumours of Colorectal Cancer

Zhu X, Ge B, Wen L

OncoTargets and Therapy 2026, 19:621109

Published Date: 15 June 2026

Review

Bladder-Preserving Platforms for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer

Zhang K, Ren Y

OncoTargets and Therapy 2026, 19:614003

Published Date: 15 June 2026

Original Research

A Nomogram Integrating HOXA9 Expression and Clinicopathological Factors for Predicting Postoperative Recurrence in Gastric Cancer: A Single-Center Retrospective Study

Weng J, Ying J, Xia M, Xie Y

OncoTargets and Therapy 2026, 19:596270

Published Date: 6 June 2026


Read more articles